However, inhibition of ELAVL1-mediated autophagic cell death (also known as ferritinophagy) leads to resistance of cardiac myocytes to ferroptosis-induced injury[55], implying that inhibiting the autophagic regulation of ferroptosis is a promising target for the treatment of MI/RI. The gene discussed is ELAVL1; the disease is myocardial infarction.